Fineotex Chemical reported robust FY26 results with revenue up 45% to Rs 772 Cr and PAT at Rs 125 Cr. The company also acquired a US-based specialty chemicals firm, expanding capacity.
Fineotex Chemical Reports Strong FY26 Growth and Strategic Acquisition
Fineotex Chemical's revenue for the fiscal year 2025-26 reached Rs. 772.23 crore, a significant increase from Rs. 533.33 crore in the previous year.
Profit after tax (PAT) for the same period stood at Rs. 125.02 crore, up from Rs. 109.21 crore in the prior year.
Reader Takeaway: Strong revenue growth and US acquisition signal expansion; fundraising and RPTs need shareholder watch.
What just happened
Fineotex Chemical Ltd has announced its financial results for the fiscal year 2025-26, reporting a consolidated revenue of Rs. 772.23 crore, an increase of 45% compared to Rs. 533.33 crore in FY 2024-25. The consolidated Profit After Tax (PAT) for FY26 was Rs. 125.02 crore, up from Rs. 109.21 crore in the previous fiscal year. The company also expanded its manufacturing capacity to 1,48,000 MTPA following the acquisition of a 53.33% stake in US-based CrudeChem Technologies Group in December 2025 and the commissioning of a new facility in Ambernath in August 2025.
Why this matters
The strong financial performance, coupled with strategic expansion through acquisition and capacity addition, positions Fineotex Chemical for continued growth. The acquisition of CrudeChem provides access to the North American oilfield market, diversifying the company's revenue streams and geographical presence. The proposed fundraising aims to fuel further expansion and working capital needs.
The backstory
Fineotex Chemical has been focused on expanding its specialty chemicals portfolio and global reach. The recent acquisition of CrudeChem Technologies Group in December 2025 is a key move to bolster its presence in the oilfield chemicals sector. The commissioning of the Ambernath facility in August 2025 also underscores the company's commitment to increasing its production capabilities.
What changes now
The acquisition of CrudeChem Technologies Group is expected to integrate the company into the North American oilfield market, enhancing its manufacturing capacity and product offerings. The proposed fundraising of up to Rs. 800 crore through QIP or Preferential Issue will provide capital for further capital expenditure, working capital, and potential inorganic growth opportunities.
Risks to watch
Shareholders will be closely watching the integration process of CrudeChem and its contribution to the company's performance. The material related-party transactions with subsidiaries for up to Rs. 500 crore also require careful monitoring. Dependence on key markets and raw material price fluctuations could pose risks.
Peer comparison
Fineotex Chemical operates in the specialty chemicals sector, competing with domestic and international players. Its focus on niche segments like oilfield chemicals and textiles provides a competitive edge. Companies like Aarti Industries, Alkyl Amines, and SRF are also significant players in the broader specialty chemicals landscape.
Context metrics (time-bound)
- Consolidated Revenue FY 2025-26: Rs. 772.23 Crore
- Consolidated PAT FY 2025-26: Rs. 125.02 Crore
- Consolidated EPS FY 2025-26: Rs. 1.09
- Acquisition of CrudeChem Technologies Group: December 2025
- New Facility Commissioned: August 2025
- Proposed Fundraising: Up to Rs. 800 Crore
- Material Related-Party Transactions: Up to Rs. 500 Crore for FY 2026-27
What to track next
Investors will be keen to monitor the performance of CrudeChem post-acquisition, the success of the proposed Rs. 800 crore fundraising, and the outcomes of the 23rd Annual General Meeting (AGM) on September 11, 2026, especially concerning the approval of related-party transactions and the final dividend recommendation.
